ARTICLE | Company News
United Therapeutics submits inhaled treprostinil NDA
July 1, 2008 2:00 AM UTC
United Therapeutics (NASDAQ:UTHR) submitted an NDA for an inhaled formulation of treprostinil to treat pulmonary arterial hypertension (PAH). The company markets IV and subcutaneous formulations of tr...